| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.04 |